adenosine monophosphate has been researched along with itraconazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bojkova, D; Buyck, C; Ciesek, S; Cinatl, J; De Jonghe, S; De Meyer, S; Jochmans, D; Leyssen, P; Neyts, J; Van Damme, E; Van Loock, M | 1 |
| Brunotte, L; Ludwig, S; Mecate-Zambrano, A; Rescher, U; Schloer, S; Tang, J; Zheng, S | 1 |
| Chen, W; Fan, N; Song, Y; Sun, Y; Wang, S; Wang, Y; Yan, L | 1 |
3 other study(ies) available for adenosine monophosphate and itraconazole
| Article | Year |
|---|---|
In vitro activity of itraconazole against SARS-CoV-2.
Topics: Adenosine; Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Caco-2 Cells; Cell Line, Tumor; Chlorocebus aethiops; COVID-19 Drug Treatment; Drug Repositioning; Furans; Humans; Itraconazole; Pyrroles; SARS-CoV-2; Triazines; Vero Cells; Virus Replication | 2021 |
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19 Drug Treatment; Fluoxetine; Hepatitis C, Chronic; Humans; Itraconazole; Pharmaceutical Preparations; SARS-CoV-2 | 2021 |
Itraconazole-Induced the Activation of Adenosine 5'-Monophosphate (Amp)-Activated Protein Kinase Inhibits Tumor Growth of Melanoma via Inhibiting ERK Signaling.
Topics: Adenosine; Adenosine Monophosphate; AMP-Activated Protein Kinases; Cell Line, Tumor; Cell Proliferation; Humans; Itraconazole; MAP Kinase Signaling System; Melanoma | 2022 |